Login / Signup

A germline mutation in the platelet-derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis.

Alexandros OnoufriadisBoutaina BoulouadnineGuillaume DachyToshihide HigashinoHsin-Yu HuangChao-Kai HsuMichael A SimpsonKonrad BorkJean-Baptiste DemoulinJohn A McGrath
Published in: The British journal of dermatology (2021)
Hereditary progressive mucinous histiocytosis (HPMH) is a rare, benign, non-Langerhans' cell histiocytosis limited to skin, with autosomal dominant inheritance. The disease was first described in 1988 and 18 cases from 7 different countries have been reported to date. Clinically, HPMH is characterised by red-brown papules on the face, hands, forearms and legs and usually develops in childhood or early adolescence; lesions do not tend to regress with age (Fig. 1a).
Keyphrases
  • growth factor
  • multiple sclerosis
  • low grade
  • single cell
  • depressive symptoms
  • copy number
  • mitochondrial dna
  • cell therapy
  • genome wide
  • dna repair
  • soft tissue
  • wound healing
  • dna damage
  • early life
  • mesenchymal stem cells